AXSYM SYSTEM - DIGOXIN II ASSAY

  • Modèle / numéro de série
    Model Catalog: 5B73-20 (Lot serial: 1 58020Q100 58752Q100); Model Catalog: 2213-20 (Lot serial: 66535M100 84599M200 78946M10); Model Catalog: 5B73-20 (Lot serial: Q100 74213Q100 74234Q100); Model Catalog: 5B73-20 (Lot serial: 1 71567Q100 71567Q101 72160); Model Catalog: 5B73-20 (Lot serial: 70023Q101 70393Q100 70393Q10); Model Catalog: 5B73-20 (Lot serial: 0 68957Q101 70023Q100); Model Catalog: 5B73-20 (Lot serial: 68677Q100 68677Q101 68957Q10); Model Catalog: 2213-20 (Lot serial: 85763M100.); Model Catalog: 2213-20 (Lot serial: M200 80082M200 53388M300); Model Catalog: 2213-20 (Lot serial: 0 73375M200 61699M100 64599); Model Catalog: 5B73-20 (Lot serial: 1.); Model Catalog: 5B73-20 (Lot serial: 82589Q101 83777Q100 83777Q10); Model Catalog: 5B73-20 (Lot serial: Q100 81316Q101 82589Q100); Model Catalog: 5B73-20 (Lot serial: 0 80974Q101 81169Q101 81316); Model Catalog: 5B73-20 (Lot serial: 79407Q101 79811Q100 80974Q10); Model Catalog: 5B73-20 (Lot serial: Q100 78361Q100 79407Q100); Model Catalog: 5B73-20 (Lot
  • Description du dispositif
    ABBOTT AXSYM & IMX DIGOXIN II REAGENT
  • Manufacturer
  • 1 Event

Fabricant

  • Adresse du fabricant
    MISSISSAUGA
  • Société-mère du fabricant (2017)
  • Commentaire du fabricant
    “We are in constant communication with regulatory agencies and competent authorities worldwide which allows us to implement global recalls or in-country communication quickly and effectively,” Abbott, which now owns St. Jude Medical told ICIJ in a statement. In addition to sending global notices to physicians worldwide, we also make sure that product advisories are available online and classification of product recalls and product advisories are determined by global regulatory bodies which can impact the timing in any given country. MD companies follow varying regulations in different countries. In come countries software is not regulated so a recall in one country related to software would not be classified as a recall or field action in another. In addition, review cycles within the regulatory process can be different in each country which can impact communication and recall timing.
  • Source
    HC

Un dispositif médical avec un nom similaire

En savoir plus sur les données ici